Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: A meta-analysis of case-control studies

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 21-25

  Wen, Yuan Yuan ^a   Yang, Shu Juan ^a   Zhang, Jian Xing ^a   Chen, Xin Yue ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Esophageal cancer; Folate intake; Methylenetetrahydrofolate reductase C677T; Polymorphism

Indexed keywords

EID: 84877150034     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.21     Document Type: Article

References (36)

1. Aune D, Deneo-Pellegrini H, Ronco AL, et al (2011). Dietary folate intake and the risk of 11 types of cancer: a case-control study in Uruguay. Ann Oncol, 22, 444-51.
2. American Cancer Society (2008). Cancer facts and figures 2008. American Cancer Society, Atlanta.
3. Chen Y, Yin D, Deng YC, et al (2009). Relationship between MTHFR gene polymorphisms and susceptibility of esophageal cancer of Han nationality in Xinjiang. J Toxicol, 23, 429-32.
4. De Stefani E, Aune D, Boffetta P, et al (2009). Salted meat consumption and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev, 10, 853-7.
5. Egger M, Smith GD, Phillips AN (1997). Meta-analysis, principles and procedures. BMJ, 315, 1533-7.
6. Falk GW(2009). Risk factors for esophageal cancer development. Surg Oncol Clin N Am, 18, 469-85.
7. Feng CW, Fan ZM, Gao SS, et al (2006). Analysis ofmethylenetetrahydrofolate reductase and thymidylate synthase gene polymorphisms of esophageal and cardia cancerpatients. Journal of Zhengzhou University (Medical Sciences), 41, 10-4.
8. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease, a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
9. He YT, Wang YM, Zhang JH, et al (2007). Correlation between a Polymorphism in the Methylene Tetrahydrofolate Reductase Gene and Susceptibility to Carcinoma of the Esophagus and Gastric Cardia. Chin J Clin Oncol, 34, 194-7.
10. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
11. Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics 2007. CA Cancer J Clin, 57, 43-66.
12. Jiang DK, Ren WH, Yao L, et al (2010). Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk. Urology, 76, 765 e1-7.
13. Kureshi N, Ghaffar S, Siddiqui S, et al (2004). Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene. ORL J Otorhinolaryngol Relat Spec, 66, 241-5.
14. Langevin SM, Lin D, Matsuo K, et al (2009). Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett, 184, 73-80.
15. Li DQ, Diao YT, Li H, et al (2008). Association of the Polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with Risk for Esophageal Squamous Cell Dysplasia and Carcinoma. Arch Med Res, 39, 594-e600.
16. Li QD, Li H, Wang MS, et al (2011). Multi-susceptibility genes associated with the risk of the development stages of esophageal squamous cell cancer in Feicheng County. BMC Gastroenterol, 11, 74.
17. Mason JB(2009). Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev, 67, 206-12.
18. Morita M, Kumashiro R, Kubo N, et al (2010). Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol, 15, 126-34.
19. Miao XP, Xing DY, Tao W, et al (2002). Susceptibility to Gastric Cardia Adenocarcinoma and Genetic Polymorphisms in Methylenetetrahydrofolate Reductase in an At-Risk Chinese Population. Cancer Epidemiol Biomarkers Prev, 11, 1454-8.
20. Qin JM, Yang L, Chen B, et al (2008). Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol, 14, 6986-92.
21. Yu X, Zhang T, Zhang H, et al (2010). Comparison of lifestyle and living environment among high risk immigrant and low risk host residents: implications for esophageal cancer etiology. Asian Pac J Cancer Prev, 11, 1827-31.
22. Sarbia M, Stahl M, von Weyhern C, et al (2006). The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma. Br J Cancer, 94, 203-7.
23. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev, 12, 1222-6.
24. Song C, Xing D, Tan W, et al (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 3272-5.
25. Song C, Xing D, Tan W, Wei Q, Lin D (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 3272-5.
26. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev, 12, 1222-6.
27. Fang Y, Xiao F, An Z, et al (2011). Systematic review on the relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 12, 1861-6.
28. Umar M, Upadhyay R, Khurana R, et al (2010). Evaluation of MTHFR677C>T polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: a case-control study in a northern Indian population. Nutr Cancer, 62, 743-49.
29. Wang J, Sasco AJ, Fu C, et al (2008). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 17, 118-25.
30. Wang JM, Xu B, Rao JY, et al (2007). Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol, 19, 171-6.
31. Wang LD, Guo RF, Fan ZM, et al (2005). Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus, 18, 177-84.
32. Wang Y, Guo W, He Y, et al (2007). Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control, 18, 143-52.
33. Yang CX, Matsuo K, Ito H, et al (2005). Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis, 26, 1285-90.
34. Zhao P, Lin F, Li Z, et al (2011). Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer. Asian Pac J Cancer Prev, 12, 2019-23.
35. Zhang J, Zotz RB, Li Y, et al (2004). Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamouscell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol, 130, 574-80.
36. Zhang JH, Li Y, Guo Y, et al (2003). The Association of methylenetetrahydrofolate reductase C677T polymorphism and esophageal squamous cell carcinoma analyzed by lightcycler. Prog Biochem Biophys, 30, 555-9.